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Abstract
Background: Only 1-3% of ischemic stroke patients receive thrombolytic therapy. Provider barriers to adhering
with guidelines recommending tPA delivery in acute stroke are not well known. The main objective of this study
was to describe barriers to thrombolytic use in acute stroke care.
Methods: Twenty-four hospitals were randomly selected and matched into 12 pairs. Barrier assessment occurred at
intervention sites only, and utilized focus groups and structured interviews. A pre-specified taxonomy was
employed to characterize barriers. Two investigators independently assigned themes to transcribed responses.
Seven facilitators (three emergency physicians, two nurses, and two study coordinators) conducted focus groups
and interviews of emergency physicians (65), nurses (62), neurologists (15), radiologists (12), hospital administrators
(12), and three others (hospitalists and pharmacist).
Results: The following themes represented the most important external barriers: environmental and patient factors.
Important barriers internal to the clinician included familiarity with and motivation to adhere to the guidelines, lack
of self-efficacy and outcome expectancy. The following themes were not substantial barriers: lack of awareness of
the existence of acute stroke guidelines, presence of conflicting guidelines, and lack of agreement with the
guidelines.
Conclusions: Healthcare providers perceive environmental and patient-related factors as the primary barriers to
adherence with acute stroke treatment guidelines. Interventions focused on increasing physician familiarity with
and motivation to follow guidelines may be of highest yield in improving adherence. Improving self-efficacy in
performing guideline concordant care may also be useful.
Trial Registration: ClinicalTrials.gov identifier: NCT00349479
Background
Ischemic stroke is a devastating disease, affecting
approximately 600,000 adults in the U.S. every year,
leaving many survivors with significant functional limita-
tions[1]. Intravenous administration of tissue plasmino-
gen activator (tPA) is recommended by American Heart
Association (AHA) guidelines for the early treatment of
acute ischemic stroke[2,3]. However, only 1% to 3% of
all ischemic stroke patients in community settings
receive thrombolytic therapy; this is estimated to be
about half of those eligible[4,5]. This low rate suggests
numerous barriers exist at both the provider and institu-
tional levels[6].
A large proportion of patients are excluded from
treatment due to factors outside of physician control,
such as delayed presentation to the hospital. In spite of
this, provider-specific barriers remain a significant deter-
minant of low treatment rates[4,6]. Previously it has
been shown that professional education can improve
treatment rates in stroke[7]. However, for the educa-
tional effort to be successful it is critical that the effort
is tailored to the targeted populations of providers[8].
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any medium, provided the original work is properly cited.The INcreasing Stroke Treatment through INterven-
tional behavioral Change Tactics (INSTINCT) trial is a
cluster randomized, controlled trial aimed at increasing
appropriate tPA use in ischemic stroke by first deter-
mining hospital-specific barriers and then providing tar-
geted, professional educational interventions. Barriers
were determined using a partial grounded theory
method, whereby qualitative data obtained through
f o c u sg r o u pd i s c u s s i o n si sc o d e di n t ot h e m e su s i n ga
previously-described taxonomy[9]. Qualitative methods
are uniquely suited to develop understanding of com-
plex situations that are difficult to measure quantita-
tively[10]. The milieu of clinician attitudes, institutional
practices, and hospital resources involved in emergency
stroke care in the community is a prime example of
such a setting for which qualitative methods may pro-
vide important insights. Our primary objective was to
describe the qualitatively-derived barriers to clinician
compliance with guidelines recommending the use of
tPA in appropriate patients as discovered in the barrier
assessment phase of INSTINCT.
Methods
Ethics Statement
The protocol was approved by the University of Michi-
gan Institutional Review Board (IRBMED) and all rele-
vant site IRBs. Written informed consent was obtained
from all participants in focus groups and interviews.
INSTINCT Trial Overview
The INSTINCT trial is evaluating the hypothesis that
initial barrier assessment f o c u s e do nt P Au s ei ns t r o k e
followed by targeted, interactive educational interven-
tions will increase appropriate tPA use[11]. These edu-
cational initiatives were planned to be specifically
tailored to the needs of each site. A schematic of the
INSTINCT trial is depicted in Figure 1. After site selec-
tion and randomization, an initial period of barrier
assessment was conducted which involved focus groups,
interviews, and surveys. The results of the barrier assess-
ments were then used to tailor site-specific continuing
medical education (CME) lectures to the most impor-
tant barriers that participants reported. Additional inter-
ventions to improve stroke care occurred concurrently
and included assistance with clinical protocol develop-
ment, 24-7 telephone access to the University of Michi-
gan acute stroke team, mock stroke codes, and targeted
messaging. Examples of targeted messaging include
informing participants of their site’sp r o g r e s sa n dt h e
overall performance of other sites within INSTINCT
and critical incident debriefing, where a physician from
the clinical coordinating center contacted local physi-
cians to discuss specific instances of deviations from
American Stroke Association guidelines or treatment
complications. Appropriate use of tPA and total number
of stroke patients were tracked at each hospital through-
out the study period and served as the primary method
by which the INSTINCT intervention was measured.
Finally, the INSTINCT trial required the recruitment of
a local stroke champion at each site to serve as the local
principal investigator and to act as a liaison between the
INSTINCT trial clinical coordinating center and the
health care providers at each site.
Study Setting
Twenty-four hospitals were randomly selected from the
population of Michigan acute care hospitals and
matched into 12 pairs based on emergency department
volume and number of stroke patients (See Figure 1).
Hospitals that were established academic comprehensive
stroke centers were excluded. Primary stroke centers
were not excluded, but were relatively uncommon in
the hospital sample at the time of randomization. Each
pair contained an intervention site and a control site,
randomly assigned. Intervention group hospitals were
25% urban with a total aggregate annual emergency
department volume of 397,193 in 2007.
Rationale for qualitative inquiry
An overall goal of the qualitative inquiry was to design a
process which would complement existing quality
improvement programs, such as Get With the Guide-
lines (GWTG)- Stroke[12]. While GWTG-Stroke pro-
vides important tools for measuring progress, it is
limited in its specific ability to encourage clinicians to
comply with guidelines recommending intravenous tPA
to eligible stroke patients. This is of particular impor-
tance in the United States, where emergency physicians
(EPs) are typically the frontline of acute stroke care. In
most U.S. practice settings, immediate access to a neu-
rologist or stroke specialist does not exist[13]. Many
decisions regarding stroke treatment, up to and includ-
ing thrombolytic use, are made by EPs. Even in settings
with access to acute stroke teams, the emergency care
providers (physicians and nurses) need to recognize that
the patient is having a stroke and alert the stroke team.
In both instances, clinician beliefs about the relative effi-
cacy of stroke thrombolysis, physician expertise, past
experience, and concern about adverse effects influence
the efficiency and overall tone of the decision-making
process. Thus, the initial relationship at the bedside
between clinician and decision maker (patient or family
member) considering thrombolysis for stroke is both
complex and ill-defined[14]. In a large proportion of
community hospitals in the United States this role is
most commonly filled by EPs.
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The qualitative data collection and analysis methods
have been described in detail previously and are sum-
marized below[15]. During design, data collection, and
analysis, we adhered to the consolidated criteria for
reporting qualitative research (COREQ) when possible
as outlined in Table 1[16]. The qualitative inquiry
occurred in two phases. Phase 1 consisted of exploratory
focus groups that were conducted at a central meeting
of stroke champions and stakeholders from each of the
Figure 1 Overview of INSTINCT trial. Process of barrier assessments and interventions at INSTINCT hospitals.
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1. Interviewer/facilitator WJM, AMS, SMF, and PAS conducted the interviews and focus groups - with exception
of three focus groups at Champions Meeting (phase 1) facilitated by individuals in the
Acknowledgements.
2. Credentials Three physicians, two nursing study coordinators, a human subjects protection
coordinator, and a geriatric emergency medicine study coordinator performed
interviews and focus groups.
3. Occupation All facilitators were employees of the University of Michigan. PAS, AMS, SMF received
salary support from the cited NIH grant.
4. Gender All physician facilitators were male. All other facilitators were female.
5. Experience and training Half of the facilitators had prior focus group experience. A marketing professional with
experience in qualitative research provided in-person training in focus group
conduction and analysis to WJM, AMS, SMF, and PAS in February of 2007.
6. Relationship established A prior relationship between the facilitator and participants did not exist in most cases.
PAS conducted recruitment of site Principal Investigators; AMS and SMF performed site
monitoring and in some cases had a prior relationship with participants.
7. Participant knowledge of the interviewer Prior to any data collection, we provided all potential participants with an overview of
the INSTINCT study prior to signing of the informed consent. The facilitator provided a
brief introduction prior to beginning an interview or focus group.
8. Interviewer characteristics PAS, WJM, AMS, and SMF are in favor of tPA use when local conditions ensure that it
can be delivered in accordance with published guidelines. PAS is a co-author of the
2007 American Stroke Association/American Heart Association guidelines for the Early
Management of Acute Ischemic Stroke. The other facilitators recognized in the
acknowledgments section have no specific opinion for or against the treatment.
Domain 2: Study Design
9. Methodologic orientation and theory We used the taxonomy described by Cabana to categorize barriers to behavioral
change from the perspective of the physician.
8 To further describe our findings, we
used grounded theory to inductively derive additional themes that characterized the
transcripts.
10. Sampling All emergency physicians and nurses at each site were invited to participate in the
focus groups. Representatives from administration, radiology and neurology were
approached based on the recommendations of the local site PIs, thus this was
purposive sampling.
11. Method of approach Participants were identified by the local site investigators and their coordinators.
12. Sample size Our goal was to achieve participation from several stakeholders in acute stroke care at
each site. Our sampling method allowed for prioritization and customization of
targeted educational interventions at each site; this was the main objective of the
qualitative analysis.
13. Non-participation One physician decided not to participate in a focus group after the informed consent
was explained as he was concerned that his participation in another stroke study
represented a possible conflict.
14. Setting of data collection We used a large conference room at a hotel during the initial site investigator
meeting. At each of the participating hospitals, we utilized ED conference rooms,
offices, and classrooms.
15. Presence of non-participants Our protocol did not allow non participants. Any non-participants were immediately
asked to leave if they entered the room where an interview or focus group took place.
16. Description of sample Our protocol only allowed for collection of occupation. Demographic characteristics of
the participants were not collected.
17. Interview guide This was pilot tested during phase 1 and improved for phase 2. The focus group
discussion guide is available as additional file 2 (appendix_focus_group_script.doc).
18. Repeat interviews Our protocol did not specifically allow for this. In some cases, participants from the
initial site investigator meeting also participated at the site barrier assessment focus
groups or interviews. As the transcripts were de-identified to protect the subjects, the
exact number of times this occurred is unavailable, but is approximately in the 5-10
range.
19. Audio/visual recording Digital audio recordings were made and transcribed verbatim.
20. Field notes Field notes were not taken in real time. Digital recordings were rapidly reviewed upon
the return of the study team to the clinical coordinating center. In the event of
recording failure, the facilitator created field notes based on memory and the
discussion guide. Recording failure occurred in only two interviews and in no focus
groups.
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used to refine discussion guides for phase 2. During the
phase 2 barrier assessment process, both focus groups
and one-on-one interviews were conducted by the
INSTINCT trial team at each of the 12 intervention
hospitals.
Participants
Characteristics of participants
There were 30 participants in the six initial focus groups
(phase 1): 10 EPs, 15 nurses, 3 neurologists, 1 hospitalist,
and 1 pharmacist. Focus group composition during phase
1 was mixed by site and occupation and the groups ran
concurrently. In phase 2, two focus groups were con-
ducted at each of the 12 intervention sites, one of EPs and
one of primarily emergency department nursing staff. A
total of 55 EPs and 48 nurses participated in phase 2 focus
groups. Additionally, one-on-one structured interviews
were conducted with a neurologist, an administrator, and
a radiologist at each intervention site. Focus group partici-
pants were recruited by the local principal investigator
from each site. Participants with disparate opinions and
past experience were sought to enhance the diversity of
responses. The demographics of these participants were
not collected to protect anonymity.
Data Acquisition
The focus group discussion guide was developed with a
professional focus group consultant. It is included in
Additional file 1 (appendix_focus_group_script.doc). All
focus groups and interviews were digitally recorded and
transcribed verbatim.
Thematic Analysis
A pre-specified taxonomy was employed to characterize
major barriers to clinical guideline adherence[9]. Bar-
riers were broadly characterized as internal or external.
External barriers were defined to describe issues inhibit-
ing guideline adherence outside the direct control of
physicians. Internal barriers were defined as those bar-
riers that are directly related to individual physician
knowledge and attitudes. Two investigators (JJM, WJM)
independently coded the transcripts into themes using
NVIVO 7 software (QSR International). The coding
guide is presented in Table 2, with the comprehensive
coding guide used by the investigators provided in Addi-
tional File 2 (Appendix_coding_guide_v1.3.doc). The
pre-specified major themes were utilized to optimize the
process by which the major barriers were categorized
and ranked to prioritize the CME educational interven-
tions at each site. Specific textual content that provided
insights into the types of barriers at each site was used
in the design of the CME lectures. As an example, if a
participant identified that radiologists were not routinely
notified that a head CT involved a tPA-eligible patient,
the CME lecture at that site could contain specific
advice on optimizing communication between clinicians
and radiologists.
Table 1 COREQ Checklist (Continued)
21. Duration The initial site investigator meeting focus groups were about 90 minutes. The on-site
focus groups were approximately 45 minutes. The individual interviews lasted 20 - 30
minutes.
22. Data saturation While achieving data saturation is an important aspect of qualitative research, our
design did not allow for repeat site visits.
23. Transcripts returned We did not return transcripts to participants for comment and/or correction. Our
protocol did not allow for this and the transcripts had personal identifiers removed to
protect the participants in the event of a security breach.
Domain 3: Analysis and Findings
24. Number of data coder: WJM and JJM performed all coding.
25. Derivation of coding tree: The coding tree used for initial assignment into the 9 major themes is adapted from
Cabana and described in the methods.
26. Derivation of themes Major themes were derived in advance; minor themes were derived from the data
inductively.
27. Software NVivo 7 was used for data analysis and management.
28. Did participants provide feedback on the findings At educational interventions later, although protocol did not allow for collection of this
data.
29. Quotations presented See results section
30. Data and findings consistent (was there consistency
between the data presented and the findings)
Questions 30-32 of COREQ address the evaluation of the findings of a qualitative study
and are intended for readers of qualitative research. They are included here for
completeness. We have attempted to present our findings in this work clearly in a
manner that was consistent with the data collected.
31. Clarity of major themes
32. Clarity of minor themes
Methods and reporting according to COREQ statement.
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Lack of Guideline Agreement This barrier is coded when the text relates to the respondent not agreeing with the guidelines. This can include
but is not limited to personal interpretation of the evidence, applicability to specific patients, and lack of
confidence in the guideline developer or the process by which the guideline was developed. Similarly, this
barrier is coded if the respondent cites national or local opinion leaders who disagree with this guideline.
This barrier should also be coded if a general lack of agreement with guidelines in general (i.e. “too cookbook”)
is observed.
This category also includes being too liberal in treatment despite the presence of absolute contraindications to
treatment (such as time.)
Lack of Guideline Awareness This barrier is coded when physicians are not aware of the existence of guidelines for acute stroke care.
It is also appropriate to code this barrier in cases when the lack of awareness is in other members of the patient
care team (i.e. inpatient team being unaware of guidelines regarding blood pressure management); in such an
instance, it may also be appropriate to code as an environmental barrier if it appears to be a reflection of
institutional politics or common practice.
This code does NOT include not knowing about the existence of stroke scales.
Lack of Guideline Familiarity This barrier is coded when there is a lack of knowledge of guideline contents or the inability to properly access
or apply the guideline. This includes overuse or desire for overuse of tPA outside of the guidelines (i.e. feeling
that a strict time window is not necessary to ensure safe treatment).
This category is not meant to reflect a lack of familiarity with emergency care in general or with stroke patients
in general. However, if a respondent cites that they only see one eligible stroke patient every 5 years and do
not recall all of the inclusion and exclusion criteria, this barrier should be coded.
This barrier is coded for a reluctance to treat those at the extremes of age and at the extremes of severity since
the guidelines which do not include these clinical findings as contraindications (other than very low severity
and age < 18 years.)
Physicians and nurses who fail to recognize stroke symptoms are included here (but not EMS providers, which
are considered external to the ED and are thus coded as an Environmental Factor.).
Lack of Outcome Expectancy The physician believes that the performance of the guideline will not lead to the desired outcome or there is a
prominent, stated fear of a bad outcome.
Lack of Self Efficacy The respondent believes that they cannot perform the guideline recommendation correctly. This may be a
reflection of personal experience or available resources. (However, a lack of available resources generally should
be coded as an External Barrier - Environmental Factor.)
This can also reflect a situation in which the physician or nurse feels unable to treat the patient effectively with
the tools they are given (i.e. a vague reading from radiology makes it hard to confidently offer tPA).
Lack of Motivation Inertia can be a powerful force. This barrier should be coded when the discussion includes the difficulty in
changing clinician habit and routines.
This should also be coded when it appears that there is “reluctance” to treat. Willingness to treat, whether
physicians “like tPA” or not, and other concepts relating to physician perception reflect a lack of motivation to
comply with the guideline.
External Barriers - Environmental
Factors
This is a large category. It encompasses the environment in which care is delivered. It includes lack of resources,
institutional hurdles, lack of consultants, lack of reimbursement, and, of special importance in acute stroke care,
liability. In acute stroke care, pre-hospital, triage and overcrowding issues also fall into this category.
Issues surrounding patient geography (e.g. difficulty in EMS covering rural areas) generally should be included
here.
Inpatient floor and nursing home issues are also included under Environmental Factors.
External Barriers - Patient (and
Family) Factors
There are many patient and family factors. Some examples:
Patients may fail to recognize stroke symptoms or to present in a timely fashion.
Family preferences to receive or not receive tPA and difficulty in finding family for the consent process are
Patient Factors.
Difficulty in communication due to language barriers.
Delayed presentation due to geography would usually be an environmental factor; however if the family
decides to drive the patient instead of activating EMS this would qualify as a Patient Factor.
If the patient chooses an inappropriate level of care for their symptoms (i.e. presenting to an urgent care center
with a dense hemiparesis) that would qualify as a Patient Factor; however if EMS and the urgent care center
cannot promptly move that patient to a facility with an appropriate level of care that would then generally be
an Environmental Factor.
External Barriers - Guideline
Factors
The characteristics of the guideline itself can present a barrier. The presence of contradictory guidelines or
“position statements” would fall into this category. This includes lack of confidence in the guideline, the body or
bodies which create the guideline, and the guideline development process. If the guidelines are not felt to be
clear, this would also be in this category.
Major barrier categories and instructions used by investigators when coding the interview and focus group data.
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major themes. The three external barriers were environ-
mental factors (e.g., availability of intensive care units,
ED crowding, pharmacy or radiology), patient factors
(e.g., failure to recognize symptoms, preference to arrive
via car instead of ambulance), and guideline factors
(issues with the structure or content of guidelines in gen-
eral). The six internal barriers were the lack of familiarity,
agreement, awareness, motivation, outcome expectancy,
or self-efficacy. Each paragraph (the coding unit) was
coded for all themes found; thus each paragraph could be
assigned zero to nine themes. See Table 2 for a detailed
description of all of the major coding themes.
Major themes were derived in advance of data collec-
tion. After completion of phase 1, the two coders inde-
pendently used the phase 1 data to inductively derive
minor themes, including the various aspects of acute
stroke presentation and treatment, conceptual models of
acute stroke presentation, and the overall process of
stroke onset to outcome. These minor themes were
then coded for both phase 1 and 2 data for the develop-
ment of the site-specific educational interventions. Bar-
riers were also related to the various phases of acute
stroke presentation and treatment. External barriers
were related to the conceptual models of the acute
stroke presentation. Barriers were related to the points
in the overall process from stroke onset to outcome.
Timeline
Phase 1 of the barrier assessments occurred at the initial
site investigators’ meeting on 3/26/2007. Phase 2 of the
barrier assessments was conducted at each of the inter-
vention hospitals from 6/12/2007 to 10/05/2007. The
thematic analysis occurred from July to October 2007
and was used to design and prioritize educational inter-
ventions for the trial. The short lead time from barrier
assessment to intervention was the rationale for the
semi-quantitative approach (relative barrier proportions)
that was utilized to determine the most discussed bar-
riers from each site.
Results
Since the external barriers of environmental and patient
factors comprised most of the cited barriers, sub-cate-
gories were inductively derived from these two major
themes to better inform the sites during the educational
intervention. The derived subcategory themes of barriers
external to the EP are described in Table 3 and provided
within the framework of acute stroke presentation in
Figure 2. The temporal process of stroke occurrence,
presentation, treatment and recovery that leads to the
final outcome is shown.
Examples of responses which are illustrative of impor-
tant internal barriers are provided in Table 4. The quo-
tations were edited for readability but no substantive
changes were made. Text added for clarity has been
placed in brackets. When considering the internal bar-
riers, nine of twelve hospitals cited guideline familiarity
as most important (see Figure 3). Additionally, for eight
of twelve hospitals, the top three cited barriers were
guideline familiarity, provider motivation, and provider
outcome expectancy. In contrast, lack of agreement with
guidelines and lack of awareness of the presence of
guidelines were the least important barriers for ten of
the twelve hospitals.
The external barriers of environmental factors and
patient factors dominated the barriers discussed for
every hospital (Figure 3a) and for all participant types. A
great deal of discussion focused on the environmental
Table 3 Sub Categories of Identified Barriers External to
the Individual Provider
Environmental Factors n Patient Factors n
Radiology 195 Delayed presentation 92
-Access to scanner 43 Symptom recognition -
patients/family
50
-Acute stroke
communication
79 Family issues 15
-Interpretation
confidence
51 Language 5
Limited neurology 108 Adverse to taking ambulance 5
ED overcrowding 54 Demand for tPA 4
Laboratory 49 Age of population 2
EMS 46
-Hospital notification 4
-Speed 9
-Symptom recognition 16
Pharmacy and drug Delivery 39
Liability 39
Lack of a protocol 38
Triage 36
Difficulty arranging for
transfer
31
Inpatient/ICU Bed
Availability
26
Limited neurosurgery 24
Lack of follow up feedback 18
Geography 14
Financial issues 9
Transfer from clinics 6
Inaccurate patient weight 4
External barriers that were categorized into themes. The numbers represent
the total number of times these items were discussed as a barrier (within the
coding unit or paragraph of a transcript). For example, four separate
paragraphs had reference to the inaccurate patient weight barrier. This could
have been four separate responses from one participant or four separate
responses from four participants. Since each paragraph could be assigned
anywhere from zero to nine major themes, and an unlimited number of
minor themes there is no total or denominator for the coded responses.
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regarding failure of adequate communication of the time
sensitive nature of computed tomography (CT) ordering
and interpretation. Interestingly, radiologists in some
cases also discussed the lack of a specific process to alert
them to the emergent nature of these CT scans. The lim-
ited availability of neurology was frequently discussed as
well. In some areas this was a general lack of neurologists
and in others it reflected a lack of evening/weekend cov-
erage. Fear of liability both for giving and not giving tPA
also received moderate attention as an external barrier.
Within the internal barriers (Figure 3b), most partici-
pants identified lack of guideline familiarity as a large
component of their hospital’s barriers. Most also had
either outcome expectancy or motivation as an impor-
tant barrier. The lack of self-efficacy appeared to be an
important contributing barrier in several hospitals as
well. When considering barriers organized by type of
provider, the external barriers of environment and
patient-controlled factors again dominated the perceived
barriers (see Figure 4a). Regarding the internal barriers,
nurses perceived lack of guideline familiarity as the
most important barrier whereas physicians (both EPs
and neurologists) perceived physician motivation as the
primary barrier (see Figure 4b). Of the barriers defined
as internal to physicians, the most important were famil-
iarity with and motivation to adhere to the guidelines,
self-efficacy, and outcome expectancy.
Discussion
We investigated barriers to the provision of thromboly-
sis for stroke in a randomly selected group of commu-
nity hospitals, focusing on the beliefs and experiences of
health care providers most like l yt ob ei n v o l v e di np r o -
viding acute stroke care. In general, almost half of the
discussed barriers were considered external to the provi-
der (e.g., systems issues, patient delays). The barriers
internal to the provider were prioritized according to a
model of physician behavior change[9].
The hospital barrier assessment process was important
because although the top barriers were similar across sites,
there was still inter-site variability. This stresses the need
Figure 2 Relationship of acute stroke care process to barriers external to the emergency physician. The pathway shows the process a
patient would go through when presenting with an acute stroke. The relationship of the identified external barriers to each point on this
pathway is demonstrated here.
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der barriers. The optimal and efficient design of interven-
tions to improve health processes requires a firm
understanding of the knowledge and attitudes of the
group targeted for the intervention[17]. This is analogous
to establishing understanding of the pathophysiology and
course of disease prior to the development of a treatment.
Past work on barriers to thrombolysis has focused on
patient- or hospital-level characteristics and not provi-
der-level barriers[4,6]. Our focus centered on the knowl-
edge and attitudes of the providers at the bedside who
were deciding whether and how to offer thrombolysis to
stroke patients. Providers were cognizant of the impor-
tance of delayed presentation and the difficulties inher-
ent in patient and family symptom recognition and
often reported these as important barriers. Further work
on the exploration of the interaction between the physi-
cian offering therapy and the patient or family member
deciding on receiving therapy could provide additional
insights into improving treatment rates.
The finding that EPs frequently cited lack of motivation
to adhere to, and lack of familiarity with, the content of
guidelines for stroke thrombolysis is intuitive. An exam-
ple of this is the observation that physicians will repeat-
edly examine patients looking for improvement to justify
withholding treatment. Prior and current ongoing meth-
ods of examining thrombolytic utilization and eligibility
have not captured this. Designing interventions that
recognize treatment should occur promptly to combat
this hesitancy is important, particularly since providers
may delay even further with the recent publication of
data that potentially expands the time window for throm-
bolysis[18,19]. The lack of familiarity with the guidelines
cited as a barrier by many respondents often focused on
specific procedural issues such as blood pressure control.
Difficulty with these and other aspects of the post-treat-
ment guidelines have been observed in prior cohorts of
thrombolytic treated stroke patients, although prior
investigations focusing on clinician failure to treat
patients meeting criteria have been limited[20]. The qua-
litative methodology utilized in the current investigation
was crucial to identifying these important issues and
others that have not been captured by prior reviews of
thrombolytic cases or EP surveys.
The relative minimal importance ascribed to a lack of
agreement with the guidelines is surprising, especially in
light of the past controversy that stroke thrombolysis has
generated within the field of emergency medicine[21,22].
This implies that changing physician practice with regard
to stroke thrombolysis may not require changing minds,
per se. Instead, increasing physician familiarity, confidence
(self-efficacy), and motivation to deliver the treatment are
likely to be of higher yield. Further investigation of the
limited guideline disagreement perceived by EPs will be
Table 4 Barriers Internal to the Individual Provider
Barrier Type of
Participant
Representative response
Lack of Guideline
Agreement
Emergency
Physician
“They were rightfully upset when suddenly, based on one study [NINDS], when you had five previous
studies that...had bad outcomes. Three of them they stopped early because of the bad outcomes. And yet
here we were asked to change our therapy based on this one study.”
Emergency
Physician
“A lot of it has to do with how much influence certain big-shots in emergency medicine have. There are
some - one in particular who practices at Hospital X, just 10 miles down the road, he’s been very outspoken
against the use of tPA. And if you ever go to the national [emergency medicine] meetings and listen to
these...docs speak, they can be very convincing. And I think that has had some influence on some people.”
Lack of Guideline
Awareness
Neurologist “... when the patient goes to the neuroscience unit, and their blood pressure goes out of the parameters, I
mean they don’t initially call the neurologist, ...usually it’s the family medicine resident. Unless the
neurologist has specifically written something else.”
Lack of Guideline
Familiarity
Emergency
Physician
“Did you say, 20 percent of patients that received placebo [in the NINDS trial] die? Twenty percent? That’s
impossible.”
Lack of Outcome
Expectancy
Emergency
Physician
“And I have used it probably three times, and I’ve really been unable in the emergency department to see
any significant improvement. I don’t think I’ve had any complications, but oftentimes I don’t get much
feedback on how my patients do later on, so I’m not really sure how they did.”
Lack of Self-Efficacy Emergency
Physician
“...some physicians are less comfortable with the whole process. You know, [some physicians would] explain
risk-benefits to families, and [would not be] giving the lytics without prior discussion with the neurologist, or
some other ER physicians would be comfortable without ever talking to neurologists, and doing everything
and then just coordinating care with the intensivists.”
Lack of Motivation Emergency
Nurse
“And they’ll go back in there and double-check that patient seven times in order to say, oh, they’re
improving, you know, as one of the relative contraindications... Their stroke scale score was 14 and now it’s
12, so they’re improving– we don’t have to give it. You know. Whew! That kind of a thing.”
Representative responses from participants that were coded as barriers. All internal barrier types are included.
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tated through quantitative survey data. In addition, a small
number of hospitals seemed to have clusters of higher per-
ceived guideline disagreement. This suggests that cluster-
ing within physician groups is an important consideration
for evaluating and improving barriers to care.
Our separate interviews with nurses and EPs provided
unique findings. The repeated re-examination phenom-
enon was described by emergency department nurses.
This specific example typifies the perceived barrier that
was cited as most important by many nurses: lack of
motivation. The picture that is painted is that of the
clinician who is uncomfortable and unsure when faced
with the potential of having to administer a thromboly-
tic agent. It is doubtful if this barrier would have been
articulated as clearly without interviews restricted to
individual provider types.
This work has several important limitations. We did
not generally seek “saturation” by performing repeat
focus groups with the intent of further delving more
Figure 3 Distribution of cited barriers by individual hospital. Overall, the dominant barriers reported were external barriers and patient
related factors.
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omy to classify responses, which might have missed bar-
riers that did not fit well into any of the categories. The
integration of these results with quantitative methods
and overall response to the targeted educational inter-
ventions (as evidenced by change in tPA treatment
rates), is not possible at this point in the overall trial.
We focused only on 12 hospitals within Michigan, and
while these hospitals came from diverse geographic and
socioeconomic areas, these findings may not be widely
generalizable. There is a potential that participants in
the focus groups and interviews were generally more
positive towards stroke thrombolysis, although it is also
plausible that participants with strong negative opinions
would also be extremely motivated to participate. Over-
all it appears that a range of opinions were represented
by our participants. This contributes to the richness of
the findings of the current investigation.
Conclusions
In summary, healthcare providers responsible for acute
stroke treatment perceive environmental and patient
factors as the most important barriers to adherence with
the AHA acute stroke guidelines. With respect to inter-
nal barriers, nurses perceived lack of guideline familiar-
ity as the biggest barrier whereas physicians (both EPs
and neurologists) perceived physician motivation as the
primary barrier. Overall, the minimal discussion of lack
of physician agreement as a barrier is interesting in light
of ongoing controversy over the use of tPA for stroke in
the field of emergency medicine. Greater knowledge of
the barriers which impede the widespread adoption of
acute stroke thrombolysis is crucial to designing effec-
tive educational interventions to improve guideline
adherence and may be informative in other areas where
difficult risk/reward decisions are made on an emergent
basis.
Figure 4 Distribution of cited barriers by acute stroke care provider type. In general, nurses perceived lack of guideline familiarity as the
biggest barrier whereas physicians (both EM and neurologists) perceived physician motivation as the primary barrier.
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Additional file 1: This is the final focus group script that was used
for emergency physician or nurse focus groups.
Additional file 2: This is the coding guide developed by the
investigators with conventions used in assigning themes.
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